Instant Saliva Testing Devices

Instant Saliva Testing Devices Market Outlook

The global instant saliva testing devices market is projected to reach USD 1.5 billion by 2035, growing at a CAGR of 9.3% during the forecast period from 2025 to 2035. The increasing prevalence of substance abuse, the growing emphasis on quick diagnostic methods in healthcare settings, and the rising demand for non-invasive testing methods are the primary factors driving this market's growth. Additionally, advancements in testing technologies and increased R&D investments by key players in the market are also expected to contribute to rapid market expansion. The convenience and accuracy of saliva testing compared to traditional methods further make it an attractive option for various applications, ranging from drug testing to genetic analysis. As a result, the market is witnessing a surge in product innovations aimed at enhancing testing efficiency and user experience.

Growth Factor of the Market

The growth of the instant saliva testing devices market is significantly driven by the increasing need for rapid and accurate diagnostic solutions across various sectors. A notable factor is the rising awareness regarding the dangers of substance abuse, which has led to stringent regulations and policies mandating drug testing in workplaces, schools, and rehabilitation centers. Furthermore, the recent public health crises, such as the COVID-19 pandemic, have accelerated the acceptance and demand for non-invasive testing methods, highlighting the need for quick and reliable results. Saliva testing not only provides a user-friendly alternative to blood testing but also minimizes the risk of infection, thus becoming a preferred choice in many scenarios. The expansion of telehealth services is also contributing to market growth as more individuals seek accessible testing solutions from the comfort of their homes. This trend is likely to continue as healthcare providers adapt to the evolving landscape of patient care, leveraging technology for improved outcomes.

Key Highlights of the Market

• The market is anticipated to grow at a CAGR of 9.3% through 2035.
• Demand for non-invasive testing methods is on the rise across healthcare sectors.
• Regulatory bodies are imposing stricter drug testing mandates, boosting market growth.
• Technological advancements are enhancing the accuracy and speed of testing.
• Telehealth expansion is increasing the utilization of saliva testing devices.

By Product Type

Oral Fluid Collection Devices:

Oral fluid collection devices are essential components in the instant saliva testing devices market. These devices facilitate the non-invasive collection of saliva samples, which can then be used for various types of tests, including drug, alcohol, and DNA testing. Their design typically emphasizes user-friendliness and accuracy, ensuring that the collection process is straightforward and minimizes contamination risks. With the increase in workplaces implementing drug screening policies, oral fluid collection devices have gained popularity for their convenience and ability to obtain a fresh sample on-site. The growth of this segment is further supported by ongoing innovations that enhance the efficiency of saliva collection, making it an appealing choice for both clinical and home testing applications.

Saliva Alcohol Testing Devices:

Saliva alcohol testing devices are increasingly gaining traction due to their role in providing immediate feedback on an individual's alcohol consumption levels. These devices work by detecting the presence of ethanol in saliva, offering a non-invasive and rapid testing method. They are particularly useful in workplace environments where regular alcohol testing is necessary for safety regulations and compliance. The accuracy and reliability of saliva alcohol testing devices have significantly improved with recent technological advancements, making them a preferred choice for organizations aiming to maintain a safe work environment. Additionally, their portability and ease of use contribute to their growing adoption in various settings, including law enforcement and emergency services.

Saliva Drug Testing Devices:

Saliva drug testing devices represent a critical segment of the market, providing an efficient means to screen for illicit substances. Saliva testing has become increasingly popular, especially in situations where immediate results are necessary, such as in workplaces, schools, and rehabilitation facilities. The devices are designed to test for a wide range of drugs, including cannabis, opiates, amphetamines, and cocaine, making them versatile tools in the fight against substance abuse. Their non-invasive nature and the ability to conduct tests in real-time offer significant advantages over traditional urine or blood testing methods. As drug abuse rates rise, the demand for saliva drug testing devices continues to grow, positioning this segment as a key player in the overall market landscape.

Saliva DNA Testing Devices:

Saliva DNA testing devices are carving a niche in the market, primarily due to the increasing interest in genetic testing for health risk assessments and ancestry purposes. These devices allow for the easy collection of saliva samples to analyze genetic material without the discomfort associated with blood draws. The accuracy and reliability of DNA tests have improved significantly, attracting consumers interested in personalized medicine and genetic predispositions to certain health conditions. As awareness of genetic testing grows, so does the demand for saliva DNA testing devices, particularly among health-conscious individuals and those seeking to understand their genetic background. The market is likely to experience robust growth as more people adopt these testing methods as part of their healthcare routine.

Saliva pH Testing Devices:

Saliva pH testing devices serve an important role in assessing oral health and overall body wellness. By measuring the pH level in saliva, these devices can provide insights into a person's dietary habits and potential health issues, such as acid reflux or metabolic disorders. The growing emphasis on preventive healthcare and self-monitoring is driving the adoption of saliva pH testing devices among consumers looking to manage their health proactively. As healthcare shifts towards personalized approaches, these devices offer an accessible way for individuals to gather valuable health information quickly. The rising trend of wellness and health optimization is expected to positively impact the market for saliva pH testing devices.

By Application

Drug Testing:

The application of instant saliva testing devices for drug testing has seen significant growth in recent years. Saliva drug testing is favored for its rapid results, ease of collection, and non-invasive nature. Many organizations, including workplaces and schools, have implemented saliva drug testing programs to ensure a drug-free environment. Moreover, these tests can detect recent drug use, making them particularly valuable for monitoring ongoing compliance with sobriety standards. As public awareness regarding substance abuse continues to rise, the demand for saliva testing solutions in this application area is expected to increase further.

Alcohol Testing:

Alcohol testing is another critical application for instant saliva testing devices, especially in environments where safety is paramount, such as transportation and heavy industries. Saliva alcohol testing devices provide immediate results, allowing employers to assess employees' sobriety efficiently. These devices are designed to detect recent alcohol consumption, which is crucial for preventing workplace accidents. The increasing implementation of zero-tolerance policies in many businesses is contributing to the growth of this segment, as companies prioritize employee safety and compliance with regulations. Additionally, the convenience and accuracy of these tests make them a preferred choice in various scenarios, including law enforcement and roadside checks.

Infectious Disease Testing:

Infectious disease testing using saliva has gained momentum, especially in light of recent global health challenges. Saliva testing can be utilized to screen for a variety of infectious diseases, including COVID-19, flu viruses, and other respiratory pathogens. The non-invasive nature of saliva collection paired with the speed at which results can be obtained makes this application particularly appealing for large-scale testing efforts during public health emergencies. The demand for rapid testing solutions is likely to foster growth in this application segment, as healthcare providers and public health organizations seek efficient methods for disease surveillance and control.

Forensic Testing:

Forensic testing applications for instant saliva testing devices are becoming increasingly relevant, particularly in criminal investigations and legal proceedings. Saliva can serve as a critical biological sample, containing DNA and other substances that can be analyzed for identification and evidence purposes. The ability to collect saliva samples easily in the field can enhance the efficiency of forensic investigations, providing law enforcement agencies with valuable data quickly. As forensic science continues to evolve and advance, the integration of saliva testing into standard operating procedures for criminal investigations is expected to grow, further expanding the market.

Genetic Testing:

Genetic testing is an emerging application area for instant saliva testing devices, driven by the growing interest in personalized medicine and consumer genetics. Saliva samples can be analyzed for a variety of genetic markers that indicate predispositions to certain health conditions or inherited traits. This application appeals to a broad audience, including those seeking insight into their ancestry and potential health risks. As individuals become more health-conscious and aware of the benefits of preventive healthcare, the demand for saliva-based genetic testing is expected to rise. This trend presents opportunities for companies to innovate and develop new testing solutions that cater to the evolving needs of consumers.

By Distribution Channel

Hospitals & Clinics:

The distribution of instant saliva testing devices through hospitals and clinics remains a primary channel, driven by the need for accurate and rapid diagnostic tools in healthcare settings. These institutions are increasingly adopting saliva testing for various applications, including drug and alcohol testing, due to its convenience and non-invasive nature. Hospitals and clinics benefit from the ability to conduct immediate tests, facilitating quick decision-making for patient care. As healthcare organizations continue to focus on improving patient outcomes and operational efficiency, the reliance on saliva testing devices is expected to grow, bolstering this distribution channel's significance in the market.

Diagnostic Laboratories:

Diagnostic laboratories play a crucial role in the distribution of saliva testing devices as they are responsible for conducting a high volume of tests and analyses. These facilities provide a level of expertise necessary for accurate test interpretations and diagnoses. Saliva testing devices are increasingly being integrated into laboratory workflows, allowing for streamlined testing processes and timely results. As the demand for testing services continues to rise, particularly in light of public health needs, diagnostic laboratories are likely to become key players in the growth of the saliva testing market, offering a reliable avenue for distribution and analysis of these innovative devices.

Home Care Settings:

The home care settings distribution channel for instant saliva testing devices is gaining traction as consumers seek more convenient healthcare solutions. The rise of telemedicine and increased focus on personal health management have propelled the demand for at-home testing options. Saliva testing devices designed for home use are typically user-friendly and provide quick results, allowing individuals to monitor their health without the need for frequent visits to healthcare providers. This shift towards self-testing empowers consumers to take charge of their health and wellness, contributing to the expansion of this distribution channel within the market.

Workplace Testing:

Workplace testing is an essential distribution channel for saliva testing devices, particularly for drug and alcohol screening programs. Employers are increasingly investing in testing solutions to ensure a safe work environment and to comply with regulations. Saliva testing provides a fast and reliable method to assess employee sobriety, making it a preferred choice for many organizations. The ability to conduct on-site testing enhances convenience and efficiency, allowing for immediate results and decision-making. As companies continue to prioritize employee safety and well-being, the reliance on saliva testing devices in workplace settings is expected to grow, solidifying this distribution channel as a vital market segment.

Online Retail:

The online retail channel for instant saliva testing devices is becoming increasingly popular as consumers seek accessible and convenient purchasing options. E-commerce platforms offer a wide variety of testing devices, allowing individuals to compare products and read reviews, ultimately aiding them in selecting the right testing solution for their needs. The COVID-19 pandemic has accelerated the trend towards online shopping, and this shift has extended into health and wellness products, including saliva testing devices. As more consumers embrace online purchasing, the online retail channel is likely to see substantial growth in the market, providing a viable alternative to traditional retail avenues.

By Technology Type

Immunoassay-Based:

Immunoassay-based technology is widely utilized in instant saliva testing devices, particularly for drug and alcohol testing applications. This technology leverages antigen-antibody reactions to detect the presence of specific substances in saliva samples. Its sensitivity and specificity make it a reliable choice for testing, allowing for accurate results in a short amount of time. The simplicity of the immunoassay method contributes to its popularity, especially in point-of-care settings where rapid results are crucial. As the demand for quick and effective testing solutions continues to grow, the immunoassay-based technology segment is expected to flourish within the market as manufacturers innovate and enhance their devices.

Chromatography-Based:

Chromatography-based technology is another significant method employed in saliva testing devices, particularly for more complex analyses such as drug screening and toxicology testing. This technology involves separating substances in saliva samples to identify specific compounds accurately. While chromatography-based methods often require more sophisticated laboratory settings, the advancements in portable chromatography devices are making it increasingly feasible for point-of-care applications. As the need for precise analytical testing rises, chromatography-based saliva testing devices are expected to gain traction, catering to specialized market segments focused on high accuracy and detailed results.

Molecular Diagnostics:

Molecular diagnostics technology is gaining ground in the saliva testing market due to its ability to detect genetic material, pathogens, or other biomarkers with high sensitivity and specificity. This technology is particularly valuable in applications such as infectious disease testing and genetic screening. The use of molecular diagnostics allows for the rapid identification of conditions or risks, which is increasingly important in modern healthcare. As the focus on personalized medicine grows, the demand for molecular diagnostics in saliva testing devices is anticipated to expand, leading to innovations that enhance user experience and testing efficiency.

By Region

In North America, the instant saliva testing devices market is poised for substantial growth, primarily driven by the increased prevalence of drug and alcohol testing in workplaces and healthcare facilities. The region is projected to account for approximately 40% of the global market share by 2035, with a CAGR of 8.5% during the forecast period. Regulatory mandates for drug testing, coupled with the rising public awareness of substance abuse, have led to heightened demand for saliva testing solutions in the United States and Canada. The established infrastructure of healthcare facilities and the presence of key market players further bolster the growth potential of this region.

Europe is also witnessing significant growth in the instant saliva testing devices market, with an estimated market share of around 30% by 2035. The CAGR for this region is expected to be approximately 8.0%. Factors driving this growth include increasing adoption of non-invasive testing methods, advancements in technology, and growing acceptance of saliva testing in both clinical and home care settings. Countries such as the United Kingdom, Germany, and France are leading the way in terms of market demand, supported by strong healthcare systems and ongoing efforts to improve public health outcomes.

Opportunities

The instant saliva testing devices market presents numerous opportunities for growth and innovation, particularly as consumer awareness about health monitoring increases. The rising trend of wellness and preventive healthcare is encouraging individuals to take a proactive approach to their health, and saliva testing provides a convenient and non-invasive option for self-testing. Companies that can develop user-friendly, accurate, and affordable saliva testing devices are likely to capture significant market share. Furthermore, ongoing advancements in smartphone applications and telehealth platforms present avenues for integrating saliva testing with digital health solutions, expanding the potential for remote monitoring and personalized healthcare services.

Another vital opportunity lies in the expansion of saliva testing applications beyond traditional drug and alcohol testing. Emerging fields such as genetic testing, infectious disease diagnostics, and wellness monitoring all present opportunities for innovation and market penetration. As research continues to unveil the capabilities of saliva analysis, there is potential for new product development that targets specific health concerns or risk assessments. Companies that can capitalize on these emerging applications while ensuring regulatory compliance and maintaining quality standards are well-positioned for future success in this evolving market landscape.

Threats

While the instant saliva testing devices market is poised for growth, it faces several threats that could impact its trajectory. One of the primary concerns is the potential for regulatory challenges and the need for widespread acceptance of saliva testing methodologies among healthcare professionals. As the market grows, regulatory bodies may impose stringent guidelines and testing standards that could pose obstacles for manufacturers, particularly smaller firms that may struggle to comply. Furthermore, competition from alternative testing methods, such as blood or urine testing, could also limit market expansion, especially in sectors where established practices are deeply rooted.

Another significant threat to the market is the risk of inaccurate results, which could lead to false positives or negatives in drug and alcohol testing scenarios. The reliability of saliva testing devices largely depends on the technology employed, and any shortcomings in accuracy or specificity could undermine the credibility of these tests. Manufacturers must prioritize quality control and rigorous testing to address these concerns and build trust among consumers and healthcare providers alike. Additionally, public perception of saliva testing, especially in sensitive areas like drug testing, can also impact adoption rates if misconceptions persist about its reliability or effectiveness.

Competitor Outlook

• Abbott Laboratories
• Thermo Fisher Scientific
• OraSure Technologies, Inc.
• Quest Diagnostics Incorporated
• Medix Biochemica
• Alere Inc. (now part of Abbott)
• Drägerwerk AG & Co. KGaA
• Rapid Detect, Inc.
• Salimetrics, LLC
• Bio-Rad Laboratories, Inc.
• Diagnostics for the Real World Ltd.
• Hawkins, Inc.
• ExamOne, A Quest Diagnostics Company
• Mylab Discovery Solutions
• Diagnostic Solutions Laboratory

The competitive landscape of the instant saliva testing devices market is characterized by a diverse range of players, from established companies to emerging start-ups. Major companies such as Abbott Laboratories and Thermo Fisher Scientific hold significant market shares due to their strong product portfolios, extensive distribution networks, and commitment to innovation. These firms are continuously investing in research and development to enhance their saliva testing technologies, ensuring they remain at the forefront of the market. Additionally, strategic partnerships and collaborations with healthcare providers and research institutions further bolster their market presence and facilitate the development of new testing solutions tailored to evolving consumer needs.

Emerging players in the market are also making significant strides, leveraging advancements in technology to create more efficient and user-friendly saliva testing devices. Companies like OraSure Technologies and Rapid Detect are focusing on niche applications such as infectious disease testing and home healthcare solutions, capitalizing on the growing trend of self-testing among consumers. The competitive dynamics are further shaped by the increasing emphasis on personalized healthcare, leading to innovations that cater to specific health concerns. As the market evolves, companies that can successfully differentiate their products and establish strong brand identities will likely gain a competitive edge over others.

Among the key players, Quest Diagnostics emerges as a significant contender in the instant saliva testing devices market, specializing in laboratory services and diagnostics. Their integration of saliva testing into existing diagnostic workflows enhances the value proposition for healthcare providers and patients alike. By combining advanced testing technologies with a robust infrastructure, Quest Diagnostics is well-positioned to meet the growing demand for saliva testing solutions across various applications. Additionally, their focus on expanding access to testing and improving turnaround times further enhances their competitive standing in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Hawkins, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medix Biochemica
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Salimetrics, LLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Rapid Detect, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Abbott Laboratories
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Thermo Fisher Scientific
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Mylab Discovery Solutions
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bio-Rad Laboratories, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 OraSure Technologies, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Quest Diagnostics Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Alere Inc. (now part of Abbott)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Diagnostic Solutions Laboratory
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Drägerwerk AG & Co. KGaA
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Diagnostics for the Real World Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 ExamOne, A Quest Diagnostics Company
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Instant Saliva Testing Devices Market, By Application
    • 6.1.1 Drug Testing
    • 6.1.2 Alcohol Testing
    • 6.1.3 Infectious Disease Testing
    • 6.1.4 Forensic Testing
    • 6.1.5 Genetic Testing
  • 6.2 Instant Saliva Testing Devices Market, By Product Type
    • 6.2.1 Oral Fluid Collection Devices
    • 6.2.2 Saliva Alcohol Testing Devices
    • 6.2.3 Saliva Drug Testing Devices
    • 6.2.4 Saliva DNA Testing Devices
    • 6.2.5 Saliva Ph Testing Devices
  • 6.3 Instant Saliva Testing Devices Market, By Technology Type
    • 6.3.1 Immunoassay-Based
    • 6.3.2 Chromatography-Based
    • 6.3.3 Molecular Diagnostics
  • 6.4 Instant Saliva Testing Devices Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Diagnostic Laboratories
    • 6.4.3 Home Care Settings
    • 6.4.4 Workplace Testing
    • 6.4.5 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Instant Saliva Testing Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Instant Saliva Testing Devices market is categorized based on

By Product Type

• Oral Fluid Collection Devices
• Saliva Alcohol Testing Devices
• Saliva Drug Testing Devices
• Saliva DNA Testing Devices
• Saliva Ph Testing Devices

By Application

• Drug Testing
• Alcohol Testing
• Infectious Disease Testing
• Forensic Testing
• Genetic Testing

By Distribution Channel

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Settings
• Workplace Testing
• Online Retail

By Technology Type

• Immunoassay-Based
• Chromatography-Based
• Molecular Diagnostics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Thermo Fisher Scientific
• OraSure Technologies, Inc.
• Quest Diagnostics Incorporated
• Medix Biochemica
• Alere Inc. (now part of Abbott)
• Drägerwerk AG & Co. KGaA
• Rapid Detect, Inc.
• Salimetrics, LLC
• Bio-Rad Laboratories, Inc.
• Diagnostics for the Real World Ltd.
• Hawkins, Inc.
• ExamOne, A Quest Diagnostics Company
• Mylab Discovery Solutions
• Diagnostic Solutions Laboratory